Advertisement

Ocular Injury by Mustard Gas; Early and Late Complications

  • Nasser ShoeibiEmail author
  • Mojtaba Abrishami
  • Alireza Eslampoor
Chapter

Abstract

Sulfur mustard (SM) is an oily liquid. It rapidly reacts with ocular tissues. Eyes are the most sensitive organs to SM. In acute phase, it results in conjunctivitis, corneal swelling and edema. Gradual spontaneous recovery usually occurs within few days of severe pain and blepharospasm, with regeneration of the corneal epithelium appearing within 5–7 days. In late stages, severe dry eye, limbal stem cell deficiency, corneal vascularization and corneal ulcers and probably retinochoroidal changes may complicate the course of disease several years after exposure. Copious irrigation, topical steroids, artificial tears, cycloplegics and corneal protection are the mainstay of treatment in acute phase. Late complications occur in a small percent of those initially severely wounded. In chronic phase, current approaches are chiefly conservative and symptomatic by nature: wearing contact lenses to improve visual acuity, managing tearing problems as well as ocular surface instability via administering artificial tears, occluding the puncta on a temporary basis, tarsorrhaphy and blepharorrhapy. Inflammation can be partially reduced using topical as well as systemic steroids. More drastic action, i.e., corneal transplantation, is needed in cases of scar formation, abnormal deposition, vascularization loss of eye sight and severe stromal thinning eventually leading to loss of global integrity.

Keywords

Sulfur mustard Mustard gas Eye Cornea Ocular surface Retina 

References

  1. Amir A, Turetz J, Chapman S, Fishbeine E, Meshulam J, Sahar R, Liani H, Gilat E, Frishman G, Kadar T (2000) Beneficial effects of topical anti‐inflammatory drugs against sulfur mustard‐induced ocular lesions in rabbits. J Appl Toxicol 20:S109–S114CrossRefPubMedGoogle Scholar
  2. Ashkenazi I, Blumenthal M, Avni I, Belkin M (1991) Mustard gas injuries of the eyes. Harefuah 120:279–283PubMedGoogle Scholar
  3. Balali-Mood M, Hefazi M (2005) The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19:297–315CrossRefPubMedGoogle Scholar
  4. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, Razavi ME, Zare G, Tabatabaee A, Jaafari MR (2005) Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 19:713–721CrossRefPubMedGoogle Scholar
  5. Banin E, Morad Y, Berenshtein E, Obolensky A, Yahalom C, Goldich J, Adibelli FM, Zuniga G, Deanda M, Pe’er J, Chevion M (2003) Injury induced by chemical warfare agents: characterization and treatment of ocular tissues exposed to nitrogen mustard. Invest Ophthalmol Vis Sci 44:2966–2972CrossRefPubMedGoogle Scholar
  6. Baradaran-Rafii A, Javadi MA, Rezaei Kanavi M, Eslani M, Jamali H, Karimian F (2010) Limbal stem cell deficiency in chronic and delayed-onset mustard gas keratopathy. Ophthalmology 117:246–252CrossRefPubMedGoogle Scholar
  7. Baradaran-Rafii A, Javadi MA, Karimian F, Feizi S (2013) Mustard gas induced ocular surface disorders. J Ophthalmic Vis Res 8:383–390PubMedPubMedCentralGoogle Scholar
  8. Batal M, Boudry I, Mouret S, Clery-Barraud C, Wartelle J, Berard I, Douki T (2014) DNA damage in internal organs after cutaneous exposure to sulphur mustard. Toxicol Appl Pharmacol 278:39–44CrossRefPubMedGoogle Scholar
  9. Blodi FC (1971) Mustard gas keratopathy. Int Ophthalmol Clin 11:1–13PubMedGoogle Scholar
  10. Britannica E (1987) Sensory reception: human vision: structure and function of the human eye. Encyclopedia Brittanica 27:179Google Scholar
  11. Brodovsky SC, McCarty CA, Snibson G, Loughnan M, Sullivan L, Daniell M, Taylor HR (2000) Management of alkali burns: an 11-year retrospective review. Ophthalmology 107:1829–1835CrossRefPubMedGoogle Scholar
  12. Etezad-Razavi M, Mahmoudi M, Hefazi M, Balali-Mood M (2006) Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications. Clin Experiment Ophthalmol 34:342–346CrossRefPubMedGoogle Scholar
  13. Feizi S, Javadi MA, Jafarinasab MR, Karimian F (2013) Penetrating keratoplasty versus lamellar keratoplasty for mustard gas-induced keratitis. Cornea 32:396–400CrossRefPubMedGoogle Scholar
  14. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM (2010) Mustard gas toxicity: the acute and chronic pathological effects. J Appl Toxicol 30:627–643CrossRefPubMedGoogle Scholar
  15. Ghanei M, Aslani J, Khateri S, Hamadanizadeh K (2003) Public health status of the civil population of Sardasht 15 years following large-scale wartime exposure to sulfur mustard. J Burns Surg Wound Care 2:7–18Google Scholar
  16. Ghasemi H, Ghazanfari T, Yaraee R, Pourfarzam S, Soroush MR, Faghihzadeh S, Babaei M, Naghizadeh MM, Mohammad Hassan Z (2012) Evaluation of the tear and serum levels of IL-8 in sulfur mustard intoxicated patients 20 years after exposure. Cutan Ocul Toxicol 31:132–137CrossRefPubMedGoogle Scholar
  17. Ghasemi H, Owlia P, Jalali-Nadoushan MR, Pourfarzam S, Azimi G, Yarmohammadi ME, Shams J, Fallahi F, Moaiedmohseni S, Moin A, Yaraee R, Vaez-Mahdavi MR, Faghihzadeh S, Mohammad Hassan Z, Soroush MR, Naghizadeh MM, Ardestani SK, Ghazanfari T (2013) A clinicopathological approach to sulfur mustard-induced organ complications: a major review. Cutan Ocul Toxicol 32:304–324CrossRefPubMedGoogle Scholar
  18. Graham JS, Schoneboom BA (2013) Historical perspective on effects and treatment of sulfur mustard injuries. Chem Biol Interact 206:512–522CrossRefPubMedGoogle Scholar
  19. Javadi MA, Baradaran-Rafii A (2009) Living-related conjunctival-limbal allograft for chronic or delayed-onset mustard gas keratopathy. Cornea 28:51–57CrossRefPubMedGoogle Scholar
  20. Javadi MA, Yazdani S, Sajjadi H, Jadidi K, Karimian F, Einollahi B, Ja’farinasab MR, Zare M (2005) Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 112:617–625CrossRefPubMedGoogle Scholar
  21. Javadi MA, Yazdani S, Kanavi MR, Mohammadpour M, Baradaran-Rafiee A, Jafarinasab MR, Einollahi B, Karimian F, Zare M, Naderi M, Rabei HM (2007) Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 26:1074–1078CrossRefPubMedGoogle Scholar
  22. Javadi MA, Jafarinasab MR, Feizi S, Karimian F, Negahban K (2011) Management of mustard gas-induced limbal stem cell deficiency and keratitis. Ophthalmology 118:1272–1281PubMedGoogle Scholar
  23. Kehe K, Thiermann H, Balszuweit F, Eyer F, Steinritz D, Zilker T (2009) Acute effects of sulfur mustard injury–Munich experiences. Toxicology 263:3–8CrossRefPubMedGoogle Scholar
  24. Keyser BM, Andres DK, Nealley E, Holmes WW, Benton B, Paradiso D, Appell A, Carpin C, Anderson DR, Smith WJ, Ray R (2013) Postexposure application of Fas receptor small-interfering RNA to suppress sulfur mustard-induced apoptosis in human airway epithelial cells: implication for a therapeutic approach. J Pharmacol Exp Ther 344:308–316CrossRefPubMedGoogle Scholar
  25. Logothetis HD, Leikin SM, Patrianakos T (2014) Management of anterior segment trauma. Dis Mon 60:247–253CrossRefPubMedGoogle Scholar
  26. McNutt P, Lyman M, Swartz A, Tuznik K, Kniffin D, Whitten K, Milhorn D, Hamilton T (2012) Architectural and biochemical expressions of mustard gas keratopathy: preclinical indicators and pathogenic mechanisms. PLoS One 7:e42837CrossRefPubMedPubMedCentralGoogle Scholar
  27. Naderi M, Jadidi K, Falahati F, Alavi SA (2010) The effect of sulfur mustard and nitrogen mustard on corneal collagen degradation induced by the enzyme collagenase. Cutan Ocul Toxicol 29:234–240CrossRefPubMedGoogle Scholar
  28. Panahi Y, Eftekhari Milani A, Sahebkar A, Naderi M, Babaei M, Beiraghdar F, Parvin S, Dadjo Y (2012) Tear total protein analysis in patients with late sulfur mustard-induced ocular complications: a cross-sectional study. Cutan Ocul Toxicol 31:104–110CrossRefPubMedGoogle Scholar
  29. Petrali JP, Dick EJ, Brozetti JJ, Hamilton TA, Finger AV (2000) Acute ocular effects of mustard gas: ultrastructural pathology and immunohistopathology of exposed rabbit cornea. J Appl Toxicol 20(Suppl 1):S173–S175PubMedGoogle Scholar
  30. Saladi RN, Smith E, Persaud AN (2006) Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol 31:1–5CrossRefPubMedGoogle Scholar
  31. Singh P, Tyagi M, Kumar Y, Gupta K, Sharma P (2013) Ocular chemical injuries and their management. Oman J Ophthalmol 6:83CrossRefPubMedPubMedCentralGoogle Scholar
  32. Solberg Y, Alcalay M, Belkin M (1997) Ocular injury by mustard gas. Surv Ophthalmol 41:461–466CrossRefPubMedGoogle Scholar
  33. United Nations Security Council (1984) Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. United Nations, New YorkGoogle Scholar
  34. Zargar M, Araghizadeh H, Soroush MR, Khaji A (2007) Iranian casualties during the eight years of Iraq-Iran conflict. Rev Saude Publica 41:1065–1066CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Nasser Shoeibi
    • 1
    Email author
  • Mojtaba Abrishami
    • 2
  • Alireza Eslampoor
    • 1
  1. 1.Eye Research CenterMashhad University of Medical SciencesMashhadIran
  2. 2.Eye Research CenterFarabi Eye Hospital, Tehran University of Medical SciencesTehranIran

Personalised recommendations